Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

LENZ Therapeutics (LENZ) Change in Account Payables: 2022-2023

Historic Change in Account Payables for Therapeutics (LENZ) over the last 2 years, with Dec 2023 value amounting to $1.1 million.

  • Therapeutics' Change in Account Payables rose 200.65% to $1.1 million in Q4 2023 from the same period last year, while for Dec 2023 it was $856,000, marking a year-over-year increase of 341.24%. This contributed to the annual value of -$4.3 million for FY2024, which is 599.88% down from last year.
  • Latest data reveals that Therapeutics reported Change in Account Payables of $1.1 million as of Q4 2023, which was down 44.74% from $2.0 million recorded in Q3 2023.
  • In the past 5 years, Therapeutics' Change in Account Payables registered a high of $2.0 million during Q3 2023, and its lowest value of -$1.6 million during Q2 2023.
  • Moreover, its 2-year median value for Change in Account Payables was $346,500 (2022), whereas its average is $131,250.
  • Over the last 5 years, Therapeutics' Change in Account Payables had its largest YoY gain of 402.30% in 2023, and its largest YoY loss of 642.86% in 2023.
  • Over the past 2 years, Therapeutics' Change in Account Payables (Quarterly) stood at -$1.1 million in 2022, then skyrocketed by 200.65% to $1.1 million in 2023.
  • Its last three reported values are $1.1 million in Q4 2023, $2.0 million for Q3 2023, and -$1.6 million during Q2 2023.